Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
The University of Helsinki seeks a Postdoctoral Researcher in Single-Cell Genomics to explore chromatin-modifying gene mutations impacting neurodevelopment. The role involves cutting-edge research utilizing single-cell and spatial profiling techniques alongside opportunities for collaboration within an emerging interdisciplinary network.
Organisation/Company UNIVERSITY OF HELSINKI Research Field Biological sciences Researcher Profile Recognised Researcher (R2) Established Researcher (R3) Country Finland Application Deadline 15 Aug 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
This project explores how mutations in chromatin-modifying genes disrupt early neurodevelopment by systematically profiling in vitro neurons using multimodal single-cell and spatial profiling. By integrating gene expression, chromatin accessibility, cell morphology, and spatial data, we aim to uncover shared regulatory disruptions across neurodevelopmental disorders.
Postdoctoral Researcher in Single-Cell Genomics through the NORPOD program
NORPOD is a collaborative postdoctoral program of theNordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and theEuropean Molecular Biology Laboratory (EMBL) , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster the next generation of researchers in molecular medicine by implementing joint postdoctoral research projects to nurture strong competences and research excellence.
FIMM is currently seeking a computational Postdoctoral Researcher to join theKilpinen group, in collaboration with theDong Won Thomas Kim groupat DANDRITE, Aarhus University, through the NORPOD program.
Summary of the project
The aim of the project is to investigate how mutations in chromatin-modifying genes, a common cause of neurodevelopmental disorders (NDDs), lead to shared disruptions in early human neurodevelopment. Using induced pluripotent stem cell (iPSC)-derived human neurons with targeted gene knockouts, we will apply multimodal single-cell and spatial profiling—including RNA-seq, ATAC-seq, cell morphology imaging, and spatial transcriptomics—to identify altered cell states and mis-patterning events. The aim is to integrate computational and experimental approaches, including validation in vivo, to uncover convergent gene regulatory mechanisms, with the goal of informing therapeutic strategies.
Tasks
The tasks will include one or more of the following:
Skills, expertise and/or qualifications
Ability to work independently as well as operating as a team player in multi-disciplinary projects is a must, and willingness to supervise students and staff is important. A good understanding of molecular biology, genomics, and bioinformatics is expected.
Research group descriptions
This NORPOD project brings together expertise from the Kilpinen group (iPSC models of NDDs, scRNA-seq, CellPainting of in vitro neurons, multimodal data analysis) and the Kim group (single-cell multiomics, gene regulatory network modelling, smfISH, in vivo perturbation tools).
Implementation
The NORPOD Fellow will be employed at the Kilpinen Group (FIMM, University of Helsinki, Finland). To promote collaboration between the two labs, this position will involve short stays at the Kim group at DANDRITE, Aarhus. Successful candidates are expected to travel between the labs to conduct work required for the research project, foster synergies and advance our goals. Expenses related to the research visits will be covered.
Contract and salary
The position is for a fixed term of 2.5 years. A trial period of six months will be applied. Salary will depend on the applicant's skills, knowledge, and abilities, and is based on the University of Helsinki salary system. The starting salary will be ca. 3,600 – 3,900 euros/month, depending on the appointee’s qualifications and experience and including a salary component based on personal performance. Standard Finnish pension benefits and occupational health care are provided for university employees.
Selection process:
How to apply:The application should include (i) two-page CV, (II) a one-page motivation statement for applying for this position, (iii) contact information of at least one reference (name, relation to candidate, e-mail and telephone number) who has agreed to provide a written statement on behalf of the applicant.
To apply, please submit the application through the University of Helsinki electronic recruitment system by clicking on Apply for job. Internal applicants (i.e., current employees of the University of Helsinki) please submit your applications through SAP Fiorihttps://msap.sap.helsinki.fi .
A diverse and equitable study and work culture is important to us. That is why we do our best to promote an inclusive university community. We encourage all qualified applicants from diverse backgrounds to apply for our positions.
Click this link to read about accessibility and inclusivity at our University .
JOIN US TO BUILD A BETTER WORLD – TOGETHER!
#HelsinkiUniCareers
The University of Helsinki is an international scientific community of 40,000 students and researchers. It is one of the leading multidisciplinary research universities and ranks among the top 100 international universities in the world.
The Institute for Molecular Medicine Finland (FIMM) is an international research unit focusing on human genomics and personalized medicine at the Helsinki Institute of Life Science (HiLIFE) of the University of Helsinki - a leading Nordic university with a strong commitment to life science research. As part of Academic Medical Center Helsinki in Meilahti campus FIMM collaborates locally with the Faculty of Medicine, Helsinki University Hospital and National Institute for Health and Welfare. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community.